ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FUM Futura Medical Plc

36.80
2.80 (8.24%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.80 8.24% 36.80 36.60 37.30 37.30 35.00 35.00 753,383 16:35:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -18.81 109.76M
Futura Medical Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FUM. The last closing price for Futura Medical was 34p. Over the last year, Futura Medical shares have traded in a share price range of 24.10p to 67.00p.

Futura Medical currently has 300,712,293 shares in issue. The market capitalisation of Futura Medical is £109.76 million. Futura Medical has a price to earnings ratio (PE ratio) of -18.81.

Futura Medical Share Discussion Threads

Showing 17726 to 17731 of 21450 messages
Chat Pages: Latest  714  713  712  711  710  709  708  707  706  705  704  703  Older
DateSubjectAuthorDiscuss
19/3/2023
12:07
LBO has no life, no work to do, and no one to talk to.

All very sad...

joestalin
19/3/2023
11:50
Joe unlike the people you publicly said were ‘clueless oafs’! Presumably they sleep very well! LOL

JoeStalin - 02 Dec 2018 - 12:13:30 - 4655 of 17404

If there was a competition for bumbling clueless oaf of the year then Barder and Theresa May will be battling for first place.

lbo
19/3/2023
11:35
LiarBO, 'Above all, don't lie to yourself. The man who lies to himself and listens to his own lie comes to a point that he cannot distinguish the truth within him, or around him, and so loses all respect for himself and for others.'

Dostoevsky

petroc
19/3/2023
11:24
He never sleeps.
joestalin
19/3/2023
10:08
Here we go !!!!

(From the web)

What’s so special about this gel?


Published in February 2018, a clinical trial showed fantastic results for Eroxon with the key factor being how fast it worked:

Within 5 minutes of applying the gel it was successful in 44% of men and within 10 minutes this success rate was 70%.

If you compare this to the current erectile dysfunction tablets that are the gold standard in treatment, they range from 15 minutes to over an hour to have their effect (depending on the brand and other factors such as stomach contents).

Viagra, or it’s generic version Sildenafil, are the most commonly used treatments and should be taken around one hour before intercourse.

mikethebike4
18/3/2023
19:17
The problem Petroc the proven multi-iD ramper has is he can never substantiate any of his false and misleading claims with any non deficient evidence. But it can be substantiated that he himself has proven the results from the deficient FM57 which was not even designed to study the placebo gel and are a ‘false positive’ ‘post hoc finding’

It was him who provided the evidence from the HCP UK website which he is now desperately trying to bury and deflect from!



‘Eroxon was the placebo used in FM57’

So now thanks to Petroc public complaints can now be made about Med3000/Eroxon to the ASA.




Its all thanks to Petroc that yet more evidence of how one misleading claim can lead to multi-ID rampers making many more false and misleading claims. All based on a flawed assumption from a false positive post hoc analysis of a study set up to study something completely different. And the application of the same subject principles of the ASA ruling on another similar drug free Class 2b medical device gel to Med3000/Eroxon. Can now mean the ASA can also find similarly that the supposedly surprising results of FM57 are actually just a ˜post hoc finding’ and ˜false positive’



Med3000 was just the placebo in the FM57 study

Therefore Futura had initially believed Med3000 had no therapeutic effect.

The FM57 study did not set out to measure the efficacy of Med3000.

The ASA will therefore consider that its reported effectiveness by Futura was a â€ËÅ“false positive’ â€ËÅ“post-hoc finding’

The CAP Code required that objective claims, including medical claims for a CE-marked medical device, be backed by evidence

a certified Class IIb medical device. We understood that the device certification was granted by a body within the European Member States that had been designated to carry out conformity assessments under the Medical Device Directive

had been used as the placebo treatment in that study, and therefore the researcher had initially believed it had no therapeutic effect. The trial did not set out to measure the efficacy

its reported effectiveness by the advertiser was a post-hoc finding due to the risk of that being a false positive finding

lbo
Chat Pages: Latest  714  713  712  711  710  709  708  707  706  705  704  703  Older

Your Recent History

Delayed Upgrade Clock